Advertisement
Editorial

Why Drug Safety Should Not Take a Back Seat to Efficacy

  • Published: September 27, 2011
  • DOI: 10.1371/journal.pmed.1001097

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies

Patricia McGettigan, David Henry
Research Article | published 27 Sep 2011 | PLOS Medicine
doi:10.1371/journal.pmed.1001098